Macrophages and cancer: from mechanisms to therapeutic implications.

By Renato Ostuni, Franz Kratochvill, P. Murray, G. Natoli. Trends in immunology, 2015

659 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology

View Paper: https://www.semanticscholar.org/paper/277cf34c1c997ac191f67f7021ba4ce3a216f829

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. S. Pun
2. Heather H Gustafson
3. Chayanon Ngambenjawong

Citations in the corpus

• Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy (2017, background): “M2 macrophages/TAM have been reported to promote tumor growth, angiogenesis, invasion, and metastasis as well as resistance to therapy [3, 4].”
• Progress in tumor-associated macrophage (TAM)-targeted therapeutics (2017, positive): “Removal of all macrophage populations regardless of polarization state has emerged as a potential therapeutic option, as there is a significant reduction in both primary and metastatic tumorigenesis [40].”